Roche’s virtual event on key neuromuscular data presented at the Muscular Dystrophy Association (MDA) scientific and clinical conference 2022
Agenda:
Welcome
Neuromuscular franchise strategy
Key Data at MDA 2022
Q&A
Bruno Eschli, Head of Investor Relations
Samir Megateli, Global Franchise Head, Neuromuscular Diseases, Global Product Strategy
Paulo Fontoura, Global Head of Neuroscience, Immunology, Ophthalmology, Infectious and Rare Diseases Clinical Development

Please register to access the replay*

*Privacy notice

Live webcast replay

Roche has hosted a virtual event on Wednesday, 14 March 2022.

Investors
Past IR Events
View more Events

Downloads

Related links